Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: A feasibility study

Radiotherapy and Oncology

Volumn 45, Issue 2, 1997, Pages 159-166

  Saunders, Michele I ^a   Hoskin, Peter J ^a   Pigott, Katherine ^a,c   Powell, Melanie E B ^a   Goodchild, Kathleen ^a   Dische, Stan ^a   Denekamp, Juliana ^b,d   Stratford, Michael R L ^b   Dennis, Madeleine F ^b   Rojas, Ana Maria ^b  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Accelerated radiotherapy; ARCON; Carbogen; Compliance; Head and neck; Nicotinamide; Side effects

Indexed keywords

CARBOGEN; METOCLOPRAMIDE; NICOTINAMIDE; ONDANSETRON; PROCHLORPERAZINE;

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DIARRHEA; DRUG EFFICACY; HEAD AND NECK CANCER; HEADACHE; HUMAN; HYPOTENSION; MUCOSA INFLAMMATION; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL IMPAIRMENT; VOMITING;

ADMINISTRATION, ORAL; AEROSOLS; ANTIEMETICS; CARBON DIOXIDE; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEASIBILITY STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; METOCLOPRAMIDE; NAUSEA; NIACINAMIDE; OXYGEN; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, HIGH-ENERGY; VOMITING;

EID: 0031282041     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)00151-5     Document Type: Article

References (42)

1. [1] Ang, K.K. and Peters, L.J. Altered fractionation in radiation oncology. In: Cancer, Principles and Practice of Oncology, pp. 1-15. Editors: V.T. Devita, S. Hellman and S.A. Rosenberg. J.B. Lippincott, Philadelphia, PA. 1994.
2. [2] Brady, L.W., Markoe, A.M., Micaily, B., Fisher, S.A. and Lamm, F.R. Innovative techniques in radiation oncology. Clinical research programs to improve local and regional control in cancer. Cancer 65: 610-624, 1990.
3. [3] Bush, R.S., Jenkin, R.D.T., Allt, W.E.C., Beale, F.A., Bean, H., Dembo, A.J. and Pringle, J.F. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br. J. Cancer 37: 302-306, 1978.
4. [4] Denekamp, J. and Fowler, J.F. ARCON: current status. Summary of a workshop on pre-clinical and clinical studies. Acta Oncol., 36: 517-525, 1997.
5. [5] Dische, S. What have we learnt from hyperbaric oxygen? Radiother. Oncol. 20 (Suppl. 1): 71-74, 1991.
6. [6] Dische, S., Anderson, P.J., Sealy, R. and Watson, E.R. Carcinoma of the cervix - anaemia, radiotherapy and hyperbaric oxygen. Br. J. Radiol. 56: 251-255, 1983.
7. [7] Dische, S., Rojas, A., Rugg, T., Hong, A. and Michael, B.D. Carbogen breathing: a system for use in man. Br. J. Radiol. 65: 87-90, 1992.
8. [8] Dische, S. and Saunders, M.I. Continuous, hyperfractionated, accelerated radiotherapy (CHART): an interim report upon late morbidity. Radiother. Oncol. 16: 65-72, 1989.
9. [9] Dische, S. and Saunders, M.I. The rationale for continuous, hyperfractionated, accelerated radiotherapy (CHART). Int. J. Radiat. Oncol. Biol. Phys. 19: 1317-1320, 1990.
10. 2 histography. Br. J. Cancer 66: 919-924, 1992.
11. [11] Fowler, J.F. How worthwhile are short schedules in radiotherapy? A series of exploratory calculations. Radiother. Oncol. 18: 165-181, 1990.
12. [12] Gatenby, R.A., Kessler, H.B., Rosenblum, J.S., Coia, L.R., Moldofsky, P.J., Hartz, W.H. and Broder, G.J. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14: 831-838, 1988.
13. [13] Haustermans, K., van der Kogel, A.J., Vanacker, B. and van der Schueren, E. Influence of combined use of nicotinamide and carbogen on rat spinal cord radiation tolerance. Radiother. Oncol. 31: 123-128, 1994.
14. [14] Horsman, M.R., Hoyer, M., Honess, D.J., Dennis, I.F. and Overgaard, J. Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy. Radiother. Oncol. 27: 131-139, 1993.
15. [15] Hoskin, P.J., Saunders, M.I., Phillips, H., Cladd, H., Powell, M.E.B., Goodchild, K., Stratford, M.R.L. and Rojas, A. Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy. Br. J. Cancer, 76: 260-263, 1997.
16. [16] Hoskin, P.J., Stratford, M.R.L., Saunders, M.I., Hall, D.W., Dennis, M.F. and Rojas, A. Administration of nicotinamide during CHART: pharmacokinetics, dose escalation, and clinical toxicity. Int. J. Radiat. Oncol. Biol. Phys. 32: 1111-1119, 1995.
17. [17] Kaanders, J.H., Stratford, M.R.L., Liefers, J., Dennis, M.F., van der Kogel, A.J., van Daal, W.A.J. and Rojas, A. Administration of nicotinamide during a five to seven week course of radiotherapy: pharmacokinetics, tolerance and compliance. Radiother. Oncol. 43: 67-73, 1997.
18. [18] Kaanders, J.H. and van der Maazen, R.W. A convenient and reliable method for carbogen breathing in man. Radiother. Oncol. 29: 341-343, 1993.
19. [19] Kolstad, P. Vascularization, oxygen tension, and radiocurability in cancer of the cervix. A colpophotographic, polarographic and clinical study. Scandinavian University Books, Universitetsforlaget, Oslo, 1964.
20. [20] Lartigau, E., Le Ridant, A.M., Lambin, P., Weeger, P., Martin, L., Sigal, R., Lusinchi, A., Luboinski, B., Eschwege, F. and Guichard, M. Oxygenation of head and neck tumors. Cancer 71: 2319-2325, 1993.
21. [21] Martin, L., Lartigau, E., Weeger, P., Lambin, P., Le Ridant, A.M., Lusinchi, A., Wibault, P., Eschwege, F., Luboinski, B. and Guichard, M. Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother. Oncol. 27: 123-130, 1993.
22. [22] Overgaard, J. Modification of hypoxia - from Gottwald Schwarz to nicotinamide: have we learned the lesson? In: Progress in Radio-Oncology, Vol. V, pp. 469-475. Editor: H.D. Kolgenik. Monduzzi Editore, Bologna, 1995.
23. [23] Overgaard, J., Sand Hansen, H., Lindelov, B., Overgaard, M., Jorgensen, K., Rasmusson, B. and Berthelsen, A. Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85. Radiother. Oncol. 20 (Suppl. 1): 143-149, 1991.
24. [24] Peters, L.J., Ang, K.K. and Thames, H.D. Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol. 27: 185-194, 1988.
25. [25] Pickels, T., Graham, P., Syndikus, I., Rheaume, D.E., Duncan, G.G., Green, A. and Mariow, C. Tolerance to nicotinamide and carbogen with radiation therapy for glioblastoma. Radiother. Oncol. 40: 245-247, 1996.
26. [26] Pigott, K., Hill, S.A., Chaplin, D.J. and Saunders, M.I. Micro regional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry. Radiother. Oncol. 40: 40-45, 1996.
27. [27] Powell, M.E.B., Hill, S.A., Saunders, M.I., Hoskin, P.J. and Chaplin, D.J. The effect of carbogen breathing on tumour microregional blood flow in humans. Radiother. Oncol., in press, 1997.
28. [28] Rojas, A. ARCON: accelerated radiotherapy with carbogen and nicotinamide. Br. J. Radiol. 24: 174-178, 1992.
29. [29] Rojas, A., Hirst, V.K., Calvert, A.S. and Johns, H. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 34: 357-365, 1996.
30. [30] Rojas, A., Hodgkiss, R.J., Stratford, M.R., Dennis, M.F. and Johns, H. Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations. Br. J. Cancer 68: 1115-1121, 1993.
31. [31] Rojas, A., Largen, P., Johns, H., Stratford, M.R.L. and Dennis, M.F. Dependence of radiosensitisation on irradiating at the time of peak nicotinamide tumour concentration. Radiother. Oncol. 40 (Suppl. 1): S21, 1996.
32. [32] Rojas, A., Vojnovic, B., Johns, H., Joiner, M.C., Martindale, C.A., Fowler, J.F. and Denekamp, J. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules. Radiother. Oncol. 39: 53-64, 1996.
33. [33] Rojas, A.M., Johns, H. and Russell, P. Should carbogen and nicotinamide be given throughout the full course of fractionated radiotherapy regimens? Int. J. Radiat. Oncol. Biol. Phys. 27: 1101-1105, 1993.
34. [34] Saunders, M.I., Dische, S., Barrett, A., Parmar, M.K., Harvey, A. and Gibson, D. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee. Br. J. Cancer 73: 1455-1462, 1996.
35. [35] Saunders, M.I., Dische, S., Grosch, E.J., Fermont, D.C., Ashford, R.F., Maher, E.J. and Makepeace, A.R. Experience with CHART. Int. J. Radiat. Oncol. Biol. Phys. 21: 871-878, 1991.
36. [36] Stratford, M.R.L., Dennis, M.F., Hoskin, P.J., Saunders, M.I., Hodgkiss, R.J. and Rojas, A. Nicotinamide pharmacokinetics in normal volunteers and patients undergoing palliative radiotherapy. Acta Oncol. 35: 213-219, 1996.
37. [37] Stratford, M.R.L., Rojas, A., Hall, D.W., Dennis, M.F., Dische, S., Joiner, M.C. and Hodgkiss, R.J. Pharmacokinetics of nicotinamide and its effect on blood pressure, pulse and body temperature in normal human volunteers. Radiother. Oncol. 25: 37-42, 1992.
38. [38] Suit, H.D. and Westgate, S.J. Impact of improved local control on survival. Int. J. Radiat. Oncol. Biol. Phys. 12: 453-458, 1986.
39. [39] Terris, D.J. and Dunphy, E.P. Oxygen tension measurements of head and neck cancers. Arch. Otolaryngol. Head Neck Surg. 120: 283-287, 1994.
40. [40] van der Maazen, R.W., Thijssen, H.O., Kaanders, J.H., de KosTer, A., Keyser, A., Prick, M.J., Grotenhuis, J.A., Wesseling, P. and van der Kogel, A.J. Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas. Radiother. Oncol. 35: 118-122, 1995.
41. [41] Wilson, G. Limitations of the bromodeoxyuridine technique for measurements of tumour proliferation. In: Current Topics in Clinical Radiobiology, pp. 27-43. Editor: H. Beck-Bornholdt. Springer-Verlag, Berlin, 1993.
42. [42] Withers, H.R., Taylor, J.M. and Maciejewski, B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27: 131-146, 1988.